A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
In this image taken from video, an IV infusion is administered at Pure Alchemy Wellness in Chula Vista, Calif., in November 2025.
Javier Arciga/AP
hide caption
toggle caption
Javier Arciga/AP
The future of peptides in the US is about to become clearer. Here’s what you should know | CNN
Peptides May Soon Be Legal. These Companies Are Ready To Cash In
U.S. FDA panel to review 7 peptides amid growing popularity | CBC News
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
FDA Set To Review Safety And Access To Peptides: What You Need To Know
What to know about the seven peptides an FDA advisory panel is set to review this week
APhA urges FDA to put patient safety first in review of peptide substances
US regulators to weigh controversial peptides backed by RFK Jr
FDA reviews peptide injections favored by RFK Jr. and wellness influencers
A little-known advisory group to the US Food and Drug Administration will meet this week to mull over whether to ease…
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and…
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if…
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1…
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back…
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding…
